New Drug Paradigm: Liquid Crystal Pharmaceuticals

An innovative liquid crystal technology that offers the promise of new drugs which may more effectively manage cancer and other diseases has been developed. The most recent research involving Liquid Crystal Pharmaceuticals has yielded a new investigational anti-tumor drug called Tolecine™, a compound that also has antiviral and antibacterial applications. It has been shown to be even more effective than the current standard of care for herpes.